Sequence signatures
A new current in care
Peptide medicine,
prescribed.
Clinician-prescribed peptide medicine from licensed U.S. pharmacies, launching state by state.
The riptideIt starts as a current.
Then it finds its sequence.
Human GLP-1 (7-37) · 31 residuesThe hormone behind today’s GLP-1 medicines.
Meet RiptideRx
A closer introduction.
The molecules, the medicine, and the thinking behind them.
Our visual language
Named for the current that pulls everything toward open water.
Licensed pharmacies
When consultations open, every prescription will be filled by a licensed U.S. pharmacy.
Radical transparency
We tell you which peptides we won’t sell, and why.
Fact-checked
Every profile checked claim by claim against primary sources.
When consultations open
The vessel.
In every detail.
Illustrative glass vial · Scroll to explore
The peptide index
Thirty molecules.
A clearer picture.
Explore the sequences, evidence, safety data and regulatory status of the 30 peptides people ask about most.
Eight categories
Eight colors. One current.
Illustrative vials. Category colors, not product packaging.
Metabolic
GLP-1 medicines and metabolic research peptides.
Growth
GHRH analogues and ghrelin-receptor agonists.
Vitality
Sexual-health and reproductive-hormone peptides.
Skin
Copper peptides, cosmetic peptides and melanocortins.
Longevity
Peptides studied in ageing and mitochondrial research.
Recovery
Peptides studied in healing research. None are FDA-approved.
Immunity
Immune-modulating peptides.
Cognition
Neuropeptides developed in Russia; unapproved in the US.
Sequence signatures
Written in the molecule.
Semaglutide
Aib at position 2 resists the enzyme DPP-4. A C18 fatty diacid on lysine 20 (Lys26 in GLP-1 numbering) binds albumin, stretching its half-life to about a week.
Tirzepatide
Aib at positions 2 and 13, and a C20 fatty diacid on lysine 20 that binds albumin, for a half-life of about five days.
Sermorelin
Identical to the first 29 residues of human growth-hormone–releasing hormone.
GHK-Cu
Glycine, histidine and lysine, holding a single copper ion.
How it works
Care starts with a clinician.
When consultations open, every prescription will start with a licensed clinician in your state, and every medication will come from a licensed pharmacy.
- 01
Consult online
Tell us what you’re interested in and complete a medical intake.
- 02
A clinician decides
A licensed clinician reviews your history and prescribes only if a treatment is appropriate for you. Sometimes the answer is no.
- 03
A pharmacy dispenses
A licensed U.S. pharmacy fills the prescription and ships it discreetly, cold-packed when the medication needs it.
Transparency
Every status.
In plain sight.
Most of the peptides people search for aren’t FDA-approved. We profile them anyway, and give every one an honest status so you know exactly where it stands.
FDA-approved brand-name medicines, or medicines compounded by a licensed pharmacy where the law allows. Prescribed only after a clinician review.
Approved for a specific condition and managed by specialists. We explain them; we don’t offer them.
FDA advisory vote, July 2026 · FDA staff opposed · no FDA action
In July 2026 an FDA advisory committee voted to recommend them for compounding, over FDA staff’s objection. FDA hasn’t acted. They are not approved and not available for sale or prescription.
Still in clinical trials. Not approved anywhere.
Not FDA-approved and not available for sale or prescription. Profiled because people ask about them.
Ingredients used in cosmetic skincare. We explain them; we don’t sell them.
Competing in sport? Many peptides are prohibited at all times under the World Anti-Doping Agency (WADA) code, including several on this site.
Check the WADA status of each peptideWhen consultations open
Start with a conversation.
Tell us what you’re interested in. When consultations open in your state, a licensed clinician will tell you, honestly, whether it’s right for you.








